Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Surgical Infections|October 13, 2023
Effect of Pre-Operative Low Serum Pre-Albumin on Surgical Site Infection in Post-Surgery Subjects: A Systematic Review and Meta-AnalysisFei Zhang, Letian Huang, MingLin Li, et al.
Leukemia|April 3, 2020
Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathwaysTeru Hideshima, Daisuke Ogiya, Jiye Liu, et al.
Blood Cancer Journal|December 10, 2023
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myelomaDebasmita Dutta, Jiye Liu, Kenneth Wen, et al.
Nature Communications|May 22, 2014
CRL4A(CRBN) E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesisJiye Liu, Jia Ye, Xiaolong Zou, et al.
Blood|July 23, 2025
A BCMA-mRNA vaccine is a promising therapeutic for multiple myelomaDebasmita Dutta, Jiye Liu, Kenneth Wen, et al.
Blood|August 27, 2020
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implicationsDaisuke Ogiya, Jiye Liu, Hiroto Ohguchi, et al.
Leukemia|July 21, 2018
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivityJiye Liu, Tianyu Song, Wenrong Zhou, et al.
Plos Genetics|January 26, 2018
CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memoryTianyu Song, Shenghui Liang, Jiye Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple MyelomaKeiji Kurata, Mehmet K Samur, Priscilla Liow, et al.
Leukemia|February 16, 2020
A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myelomaLijie Xing, Liang Lin, Tengteng Yu, et al.
Pageof 4